Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation

Genes and Development

Volumn 27, Issue 24, 2013, Pages 2648-2662

  Shi, Junwei ^a,b   Whyte, Warren A ^c   Zepeda Mendoza, Cinthya J ^a,d   Milazzo, Joseph P ^a   Shen, Chen ^a,b   Roe, Jae Seok ^a   Minder, Jessica L ^a   Mercan, Fatih ^a   Wang, Eric ^a   Eckersley Maslin, Melanie A ^a,d   Campbell, Amy E ^e   Kawaoka, Shinpei ^a   Shareef, Sarah ^a   Zhu, Zhu ^a   Kendall, Jude ^a   Muhar, Matthias ^f   Haslinger, Christian ^g   Yu, Ming ^h   Roeder, Robert G ^h   Wigler, Michael H ^a,d   Blobel, Gerd A ^e   Zuber, Johannes ^f   Spector, David L ^a,d   Young, Richard A ^c   Vakoc, Christopher R ^a,d   more..

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d WATSON SCHOOL OF BIOLOGICAL SCIENCES   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^g BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^h ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Brd4; Brg1; Enhancer; Leukemia; Myc; SWI SNF

Indexed keywords

BRG1 PROTEIN; MYC PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL RENEWAL; CELL SURVIVAL; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SELF CONCEPT; TRANSCRIPTION REGULATION;

BRD4; BRG1; ENHANCER; LEUKEMIA; MYC; SWI/SNF;

CELL LINE, TUMOR; CELL PROLIFERATION; DNA HELICASES; DNA-BINDING PROTEINS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LEUKEMIA, MYELOID, ACUTE; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS;

EID: 84890717859     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.232710.113     Document Type: Article

References (58)

1. Bakshi R., Hassan MQ, Pratap J, Lian JB, Montecino MA, van Wijnen A. J, Stein JL, Imbalzano AN, Stein GS. 2010. The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes. J Cell Physiol 225: 569-576.
2. Bernt K. M, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV, Feng Z., Punt N, Daigle A, Bullinger L, et al. 2011. MLLrearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 20: 66-78.
3. Boyer L. A, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, et al. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441: 349-353.
4. Bultman S. J, Gebuhr TC, Magnuson T. 2005. A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in β-globin expression and erythroid development. Genes Dev 19: 2849-2861.
5. The Cancer Genome Atlas Research Network. 2013. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368: 2059-2074.
6. Chi T. H, Wan M, Zhao K, Taniuchi I, Chen L, Littman DR, Crabtree G.R. 2002. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature 418: 195-199.
7. Chi T. H, Wan M, Lee PP, Akashi K, Metzger D, Chambon P, Wilson C. B, Crabtree GR. 2003. Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity 19: 169-182.
8. Cote J., Quinn J, Workman JL, Peterson CL. 1994. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 265: 53-60.
9. Dawson M. A, Kouzarides T. 2012. Cancer epigenetics: From mechanism to therapy. Cell 150: 12-27.
10. Dawson M. A, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, Robson SC, Chung CW, Hopf C, Savitski MM, et al. 2011. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478: 529-533.
11. Delmore J. E, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E., Gilpatrick T, Paranal RM, Qi J, et al. 2011. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146: 904-917.
12. Denis G. V, McComb ME, Faller DV, Sinha A, Romesser PB, Costello C.E. 2006. Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J Proteome Res 5: 502-511.
13. Dixon J. R, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, Ren B. 2012. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485: 376-380.
14. Dykhuizen E. C, Hargreaves DC, Miller EL, Cui K, Korshunov A, Kool M., Pfister S, Cho YJ, Zhao K, Crabtree GR. 2013. BAF complexes facilitate decatenation of DNA by topoisomerase IIα. Nature 497: 624-627.
15. Filippakopoulos P., Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse E. M, Keates T, Hickman TT, Felletar I, et al. 2010. Selective inhibition of BET bromodomains. Nature 468: 1067-1073.
16. Garraway L. A, Lander ES. 2013. Lessons from the cancer genome. Cell 153: 17-37.
17. Grand F., Kulkarni S, Chase A, Goldman JM, Gordon M, Cross NC. 1999. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res 59: 3870-3874.
18. Hargreaves D. C, Crabtree GR. 2011. ATP-dependent chromatin remodeling: Genetics, genomics and mechanisms. Cell Res 21: 396-420.
19. Jing H., Vakoc CR, Ying L, Mandat S, Wang H, Zheng X, Blobel GA. 2008. Exchange of GATA factors mediates transitions in looped chromatin organization at a developmentally regulated gene locus. Mol Cell 29: 232-242.
20. Kadam S., Emerson BM. 2003. Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell 11: 377-389.
21. Kadoch C., Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree G.R. 2013. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 45: 592-601.
22. Khavari P. A, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. 1993. BRG1 contains a conserved domain of the SWI2/ SNF2 family necessary for normal mitotic growth and transcription. Nature 366: 170-174.
23. Kowenz-Leutz E., Leutz A. 1999. A C/EBPβ isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell 4: 735-743.
24. Krasteva V., Buscarlet M, Diaz-Tellez A, Bernard MA, Crabtree GR, Lessard JA. 2012. The BAF53a subunit of SWI/SNF-like BAF complexes is essential for hemopoietic stem cell function. Blood 120: 4720-4732.
25. Krosl J., Mamo A, Chagraoui J, Wilhelm BT, Girard S, Louis I, Lessard J., Perreault C, Sauvageau G. 2010. A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations. Blood 116: 1678-1684.
26. Kuhn M. W, Radtke I, Bullinger L, Goorha S, Cheng J, Edelmann J, Gohlke J., Su X, Paschka P, Pounds S, et al. 2012. Highresolution genomic profiling of adult and pediatric corebinding factor acute myeloid leukemia reveals new recurrent genomic alterations. Blood 119: e67-e75.
27. Loven J., Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner J. E, Lee TI, Young RA. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153: 320-334.
28. Luo H., Li Q, O'Neal J, Kreisel F, Le Beau MM, Tomasson MH. 2005. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood 106: 2452-2461.
29. Marcucci G., Baldus CD, Ruppert AS, Radmacher MD, Mrozek K, Whitman SP, Kolitz JE, Edwards CG, Vardiman JW, Powell BL et al. 2005. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: A Cancer and Leukemia Group B study. J Clin Oncol 23: 9234-9242.
30. Mertz J. A, Conery AR, Bryant BM, Sandy P, Balasubramanian S, Mele D. A, Bergeron L, Sims RJ 3rd. 2011. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci 108: 16669-16674.
31. Neely K. E, Hassan AH, Wallberg AE, Steger DJ, Cairns BR, Wright A. P, Workman JL. 1999. Activation domain-mediated targeting of the SWI/SNF complex to promoters stimulates transcription from nucleosome arrays. Mol Cell 4: 649-655.
32. Olave I., Wang W, Xue Y, Kuo A, Crabtree GR. 2002. Identification of a polymorphic, neuron-specific chromatin remodeling complex. Genes Dev 16: 2509-2517.
33. Pedersen T. A, Kowenz-Leutz E, Leutz A, Nerlov C. 2001. Cooperation between C/EBPα TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev 15: 3208-3216.
34. Popovic R., Licht JD. 2012. Emerging epigenetic targets and therapies in cancer medicine. Cancer Discov 2: 405-413.
35. Pottier N., Yang W, Assem M, Panetta JC, Pei D, Paugh SW, Cheng C., Den Boer ML, Relling MV, Pieters R, et al. 2008. The S. WI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. J Natl Cancer Inst 100: 1792-1803.
36. Rada-Iglesias A., Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470: 279-283.
37. Radtke I., Mullighan CG, Ishii M, Su X, Cheng J, Ma J, Ganti R, Cai Z., Goorha S, Pounds SB, et al. 2009. Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci 106: 12944-12949.
38. Rahman S., Sowa ME, Ottinger M, Smith JA, Shi Y, Harper JW, Howley P.M. 2011. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol 31: 2641-2652.
39. Roberts C. W, Leroux MM, Fleming MD, Orkin SH. 2002. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2: 415-425.
40. Rosenbauer F., Tenen DG. 2007. Transcription factors in myeloid development: Balancing differentiation with transformation. Nat Rev Immunol 7: 105-117.
41. Shain A. H, Pollack JR. 2013. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS ONE 8: e55119.
42. Shen W., Xu C, Huang W, Zhang J, Carlson JE, Tu X, Wu J, Shi Y. 2007. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Biochemistry 46: 2100-2110.
43. Shen Y., Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, Wagner U, Dixon J., Lee L, Lobanenkov VV, et al. 2012. A map of the cisregulatory sequences in the mouse genome. Nature 488: 116-120.
44. Splinter E., de Wit E, van deWerken HJ, Klous P, de LaatW. 2012. Determining long-range chromatin interactions for selected genomic sites using 4C-seq technology: From fixation to computation. Methods 58: 221-230.
45. Steger D. J, Lefterova MI, Ying L, Stonestrom AJ, Schupp M, Zhuo D, Vakoc AL, Kim JE, Chen J, Lazar MA, et al. 2008. DOT1L/ KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol 28: 2825-2839.
46. Subramanian A., Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette M. A, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. 2005. Gene set enrichment analysis: A knowledgebased approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102: 15545-15550.
47. van de Werken HJ, Landan G, Holwerda SJ, Hoichman M, Klous P, Chachik R, Splinter E, Valdes-Quezada C, Oz Y, Bouwman BA, et al. 2012. Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat Methods 9: 969-972.
48. Wang W., Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C., Kalpana GV, Goff SP, Yaniv M, et al. 1996. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 15: 5370-5382.
49. Wang X., Sansam CG, Thom CS, Metzger D, Evans JA, Nguyen PT, Roberts CW. 2009. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex. Cancer Res 69: 8094-8101.
50. Williams R. T, Roussel MF, Sherr CJ. 2006. Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. Proc Natl Acad Sci 103: 6688-6693.
51. Willis M. S, Homeister JW, Rosson GB, Annayev Y, Holley D, Holly S. P, Madden VJ, Godfrey V, Parise LV, Bultman SJ. 2012. Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart. Circ Res 111: e111-e122.
52. Wilson B. G, Roberts CW. 2011. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11: 481-492.
53. Wilson N. K, Foster SD, Wang X, Knezevic K, Schutte J, Kaimakis P, Chilarska PM, Kinston S, Ouwehand WH, Dzierzak E, et al. 2010. Combinatorial transcriptional control in blood stem/progenitor cells: Genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7: 532-544.
54. Wu J. I, Lessard J, Crabtree GR. 2009. Understanding the words of chromatin regulation. Cell 136: 200-206.
55. Yin W., Rossin A, Clifford JL, Gronemeyer H. 2006. Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Oncogene 25: 3735-3744.
56. Zuber J., McJunkin K, Fellmann C, Dow LE, Taylor MJ, Hannon GJ, Lowe SW. 2011a. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat Biotechnol 29: 79-83.
57. Zuber J., Rappaport AR, Luo W, Wang E, Chen C, Vaseva AV, Shi J, Weissmueller S, Fellmann C, Taylor MJ, et al. 2011b. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev 25: 1628-1640.
58. Zuber J., Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D., Qi J, Blatt K, Wunderlich M, et al. 2011c. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478: 524-528.